Given that much of the mechanistic research into CFTR deficiency in cancer has focused on the intestinal tract, evidence for potential causative downstream mechanisms largely still comes from that tissue, with potential applicability to other GI tract cancers and/or the discovery of novel mechanisms in non-intestinal GI tract cancers. Here, CFTR is linked to cancer.